ArticleInternational journal of clinical pharmacy2023

Direct-acting antiviral agent use and gastrointestinal safety in patients with chronic hepatitis C: a pharmacovigilance study based on FDA Adverse Event Reporting System.

Wenhuo Xie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.